These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1956550)

  • 1. Cyclophosphamide pulse therapy in Wegener's granulomatosis.
    Haubitz M; Frei U; Rother U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1991; 6(8):531-5. PubMed ID: 1956550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
    Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    Hoffman GS; Leavitt RY; Fleisher TA; Minor JR; Fauci AS
    Am J Med; 1990 Oct; 89(4):403-10. PubMed ID: 2220874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.
    Drosos AA; Sakkas LI; Goussia A; Siamopoulos KC; Moutsopoulos HM
    J Intern Med; 1992 Sep; 232(3):279-82. PubMed ID: 1402626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of plasmapheresis with subsequent pulse cyclophosphamide as initial treatment of severe Wegener's granulomatosis.
    Heer A; Schroeder JO; Euler HH
    APMIS Suppl; 1990; 19():66. PubMed ID: 2285546
    [No Abstract]   [Full Text] [Related]  

  • 8. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.
    Reinhold-Keller E; Kekow J; Schnabel A; Schmitt WH; Heller M; Beigel A; Duncker G; Gross WL
    Arthritis Rheum; 1994 Jun; 37(6):919-24. PubMed ID: 8003065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Wegener's granulomatosis.
    Briedigkeit L; Ulmer M; Göbel U; Natusch R; Reinhold-Keller E; Gross WL
    Adv Exp Med Biol; 1993; 336():491-5. PubMed ID: 8296663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener's granulomatosis.
    Mitrovic D; Popovic M; Stefanovic D; Glisic B; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2378-9. PubMed ID: 11377566
    [No Abstract]   [Full Text] [Related]  

  • 12. Wegener's granulomatosis.
    Sneller MC
    JAMA; 1995 Apr; 273(16):1288-91. PubMed ID: 7715042
    [No Abstract]   [Full Text] [Related]  

  • 13. Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.
    Steppat D; Gross WL
    Klin Wochenschr; 1989 Jul; 67(13):666-71. PubMed ID: 2787871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of bronchial stenosis in Wegener's granulomatosis. Dramatic response to intravenous cyclophosphamide and oral cotrimoxazole.
    Hirsch MM; Houssiau FA; Collard P; Devogelaer JP; Nagant de Deuxchaisnes C
    J Rheumatol; 1992 May; 19(5):821-4. PubMed ID: 1613718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
    Haubitz M; Koch KM; Brunkhorst R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Wegener's granulomatosis].
    Riccieri V; Valesini G
    Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis.
    Harrison HL; Linshaw MA; Lindsley CB; Cuppage FE
    JAMA; 1980 Oct; 244(14):1599-600. PubMed ID: 7420662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis].
    Kovacević Z; Mitrović D; Tomić I; Jovanović D; Skatarić V; Dimitrijević J; Rabrenović V; Trifunović G
    Vojnosanit Pregl; 1999; 56(1):31-7. PubMed ID: 10230331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.